Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 10/14/2016
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / -||UN / IM|
Administered by: Other Purchased by: Other
Symptoms: Dizziness, Headache, Muscular weakness, Nausea, Blood test normal
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Other Medications: No other medications
Current Illness: Human papilloma virus, immunisation
Diagnostic Lab Data: Regular blood tests, substantially no abnormally.
CDC 'Split Type': WAES1603DNK008531
Write-up:Information has been received from Sanofi Pasteur MSD (MFR control number DK-DKMA-WBS-0002933) on 17-MAR-2016. Case received from a physician on 15-MAR-2016. A 12-year-old female adolescent patient received GARDASIL, (batch number unknown) via intramuscular route on 27-SEP-2012. The patient experienced nausea in December 2012, dizziness in December 2012, headache in December 2012 and weakness in the legs in December 2012. Additional investigations included Blood Test normal n/a on an unknown date. The patient''s outcome was reported as not recovered/not resolved. No other vaccines or medicines.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166